PARTNERING

Unlock the Full Potential of Your Cell Therapy

October 10, 2023

Exclusive: Cellares expands deal with Bristol Myers on preclinical CAR-T asset, eyes manufacturing expansion

Exclusive: Cellares expands deal with Bristol Myers on preclinical CAR-T asset, eyes manufacturing expansion